| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |




From the Departments of Internal Medicine D,* and Physiological Chemistry and Pathobiochemistry,
University of Münster, Münster, Germany; Pharmazentrum Frankfurt,
Institut fur Allgemeine Pharmakologie und Toxikologie/Zentrum für Arzneimittelsicherheit, Entwicklung und Sicherheit, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany; the Department of Cellular and Molecular Pathology,
German Cancer Research Center, Heidelberg, Germany; the Department of Anatomy and Cell Biology and Faculty of Dentistry,¶ McGill University, Montreal, Quebec, Canada; and the Department of Pathology,|| Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania
Decorin, a small leucine-rich proteoglycan, affects the synthesis of the elastic fiber component fibrillin-1 in the kidney via hitherto unknown mechanisms. Here, we show that decorin binds to and induces phosphorylation of insulin-like growth factor-I (IGF-I) receptor in renal fibroblasts. Inhibition of the IGF-I receptor tyrosine kinase and its downstream target phosphoinositide-3 kinase prevented decorin-mediated synthesis of fibrillin-1. Furthermore, decorin induced phosphorylation of phosphoinositide-dependent kinase 1, protein kinase B/Akt, mammalian target of rapamycin (mTOR), and p70 S6 kinase. Accordingly, the enhanced synthesis of fibrillin-1 was blocked by rapamycin, an inhibitor of mTOR. Notably, IGF-I, which signals through the same pathway, also stimulated fibrillin-1 synthesis. Systemic administration of rapamycin to mice subjected to unilateral ureteral obstruction, a model of renal fibrosis and increased fibrillin-1 synthesis, markedly reduced the number of interstitial fibroblasts and fibrillin-1 deposition. In streptozotocin-induced diabetes, IGF-I receptor was up-regulated in the kidneys from decorin-null mice. However, this could not compensate for the decorin deficiency, resulting ultimately in decreased fibrillin-1 content. This study provides evidence for the involvement of decorin and the IGF-I receptor/mTOR/p70 S6 kinase signaling pathway in the translational regulation of fibrillin-1.
This article has been cited by other articles:
![]() |
W. Lieberthal and J. S. Levine The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease J. Am. Soc. Nephrol., December 1, 2009; 20(12): 2493 - 2502. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jarvelainen, A. Sainio, M. Koulu, T. N. Wight, and R. Penttinen Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy Pharmacol. Rev., June 1, 2009; 61(2): 198 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Soderberg, B. Bystrom, S. Kalamajski, A. Malmstrom, and G. Ekman-Ordeberg Gene expressions of small leucine-rich repeat proteoglycans and fibulin-5 are decreased in pelvic organ prolapse Mol. Hum. Reprod., April 1, 2009; 15(4): 251 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaefer and R. V. Iozzo Biological Functions of the Small Leucine-rich Proteoglycans: From Genetics to Signal Transduction J. Biol. Chem., August 1, 2008; 283(31): 21305 - 21309. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |